Ana Martinez–Naharro

7.4k total citations · 1 hit paper
80 papers, 2.8k citations indexed

About

Ana Martinez–Naharro is a scholar working on Molecular Biology, Nephrology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ana Martinez–Naharro has authored 80 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 39 papers in Nephrology and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ana Martinez–Naharro's work include Amyloidosis: Diagnosis, Treatment, Outcomes (64 papers), Parathyroid Disorders and Treatments (38 papers) and Cardiac Imaging and Diagnostics (11 papers). Ana Martinez–Naharro is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (64 papers), Parathyroid Disorders and Treatments (38 papers) and Cardiac Imaging and Diagnostics (11 papers). Ana Martinez–Naharro collaborates with scholars based in United Kingdom, United States and Italy. Ana Martinez–Naharro's co-authors include Marianna Fontana, Philip N. Hawkins, Julian D. Gillmore, Carol Whelan, James Moon, Tamer Rezk, Tushar Kotecha, Daniel Knight, Peter Kellman and Candida Cristina Quarta and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Ana Martinez–Naharro

71 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A new staging system for cardiac transthyretin amyloidosis

2017 453 citations Julian D. Gillmore, Marianna Fontana et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ana Martinez–Naharro United Kingdom	26	1.9k	1.0k	1.0k	513	452	80	2.8k
Esther González-López Spain	17	1.8k 1.0×	936 0.9×	689 0.7×	118 0.2×	561 1.2×	44	2.2k
Candida Cristina Quarta Italy	29	3.8k 2.0×	1.9k 1.9×	1.3k 1.3×	218 0.4×	1.0k 2.3×	61	4.4k
Simon Gibbs United Kingdom	18	1.8k 0.9×	689 0.7×	383 0.4×	142 0.3×	499 1.1×	76	2.2k
Tamer Rezk United Kingdom	16	1.4k 0.7×	763 0.7×	453 0.4×	145 0.3×	328 0.7×	33	1.6k
Stefania Rosmini United Kingdom	24	547 0.3×	213 0.2×	1.4k 1.4×	775 1.5×	134 0.3×	69	2.1k
Imran S. Syed United States	15	519 0.3×	284 0.3×	774 0.8×	363 0.7×	132 0.3×	20	1.3k
Anna S Herrey United Kingdom	17	422 0.2×	223 0.2×	1.0k 1.0×	866 1.7×	64 0.1×	57	1.6k
Donald R. Neumann United States	21	188 0.1×	481 0.5×	388 0.4×	655 1.3×	205 0.5×	56	1.9k
Toshihiro Tamura Japan	18	494 0.3×	78 0.1×	680 0.7×	123 0.2×	52 0.1×	78	1.3k
Nikhil Joshi United Kingdom	18	296 0.2×	71 0.1×	920 0.9×	1.3k 2.5×	58 0.1×	38	2.4k

Countries citing papers authored by Ana Martinez–Naharro

Since Specialization

Citations

This map shows the geographic impact of Ana Martinez–Naharro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martinez–Naharro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martinez–Naharro more than expected).

Fields of papers citing papers by Ana Martinez–Naharro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martinez–Naharro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martinez–Naharro. The network helps show where Ana Martinez–Naharro may publish in the future.

Co-authorship network of co-authors of Ana Martinez–Naharro

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martinez–Naharro. A scholar is included among the top collaborators of Ana Martinez–Naharro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martinez–Naharro. Ana Martinez–Naharro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khwaja, Jahanzaib, Sriram Ravichandran, Oliver C. Cohen, et al.. (2025). Outcomes of daratumumab–bortezomib–thalidomide–dexamethasone in treatment‐naive systemic AL amyloidosis. British Journal of Haematology. 206(4). 1141–1148. 1 indexed citations

Patel, Rishi, Ana Martinez–Naharro, Yousuf Razvi, et al.. (2024). 5 Cardiovascular magnetic resonance (CMR) in transthyretin amyloid cardiomyopathy – a study of natural history and treatment repsonse. Abstracts. A2.1–A2. 1 indexed citations

Netti, Lucrezia, Adam Ioannou, Ana Martinez–Naharro, et al.. (2024). Microvascular Obstruction in Cardiac Amyloidosis. European Journal of Heart Failure. 27(12). 2948–2951. 4 indexed citations

Khwaja, Jahanzaib, Sriram Ravichandran, Oliver C. Cohen, et al.. (2024). Defining a New “Mayo Stage IIIc” Ultra Poor Risk Category in Systemic AL Amyloidosis: Incorporating Echocardiographic Global Longitudinal Strain to the European Modified Mayo Staging System. Blood. 144(Supplement 1). 890–890.

Khwaja, Jahanzaib, Sriram Ravichandran, Darren Foard, et al.. (2024). Prognostication in IgM and Lymphoplasmacytic Lymphoma Associated Systemic AL Amyloidosis. Blood. 144(Supplement 1). 4684–4684.

Friedrich, Matthias G., et al.. (2023). Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging. Heart Failure Clinics. 19(4). 445–459. 2 indexed citations

Starr, Neasa, Adam Ioannou, & Ana Martinez–Naharro. (2023). Monitoring cardiac amyloidosis with multimodality imaging. Revista Española de Cardiología (English Edition). 77(1). 79–87. 2 indexed citations

Ioannou, Adam, Rishi Patel, Yousuf Razvi, et al.. (2022). Abstract 10064: Tracking Multi-Organ Treatment Response in Systemic Al-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping. Circulation. 146(Suppl_1). 1 indexed citations

Quarta, Candida Cristina, David F. Hutt, Richa Manwani, et al.. (2021). 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging. 22(11). 1304–1311. 42 indexed citations

10.

Law, Steven, Aviva Petrie, Liza Chacko, et al.. (2021). Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy. Heart. 108(6). 474–478. 20 indexed citations

11.

Kotecha, Tushar, Juan Manuel Monteagudo Ruiz, Ana Martinez–Naharro, et al.. (2020). Quantitative cardiovascular magnetic resonance myocardial perfusion mapping to assess hyperaemic response to adenosine stress. European Heart Journal - Cardiovascular Imaging. 22(3). 273–281. 15 indexed citations

12.

Cohen, Oliver C., Faye Sharpley, Julian D. Gillmore, et al.. (2020). Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis. British Journal of Haematology. 189(4). 643–649. 28 indexed citations

13.

Fontana, Marianna, Ana Martinez–Naharro, Liza Chacko, et al.. (2020). Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression. JACC. Cardiovascular imaging. 14(1). 189–199. 128 indexed citations

14.

Kotecha, Tushar, Omar Chehab, Ana Martinez–Naharro, et al.. (2020). Assessment of Multivessel Coronary Artery Disease Using Cardiovascular Magnetic Resonance Pixelwise Quantitative Perfusion Mapping. JACC. Cardiovascular imaging. 13(12). 2546–2557. 42 indexed citations

15.

Kotecha, Tushar, Ana Martinez–Naharro, Michele Boldrini, et al.. (2019). Automated Pixel-Wise Quantitative Myocardial Perfusion Mapping by CMR to Detect Obstructive Coronary Artery Disease and Coronary Microvascular Dysfunction. JACC. Cardiovascular imaging. 12(10). 1958–1969. 154 indexed citations

16.

Knight, Daniel, Tushar Kotecha, Ana Martinez–Naharro, et al.. (2019). Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment – predictors of procedure success and duration in pulmonary artery hypertension. Journal of Cardiovascular Magnetic Resonance. 21(1). 57–57. 28 indexed citations

17.

Rezk, Tamer, Andrew Davenport, Helen J. Lachmann, et al.. (2018). Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis. British Journal of Haematology. 185(5). 977–980. 4 indexed citations

18.

Knight, Daniel, Giulia Zumbo, William Barcella, et al.. (2018). Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC. Cardiovascular imaging. 12(5). 823–833. 119 indexed citations

19.

Martinez–Naharro, Ana, Thomas A. Treibel, Amna Abdel‐Gadir, et al.. (2017). Magnetic Resonance in Transthyretin Cardiac Amyloidosis. Journal of the American College of Cardiology. 70(4). 466–477. 275 indexed citations

20.

Martinez–Naharro, Ana, Amna Abdel‐Gadir, Thomas A. Treibel, et al.. (2016). Abstract 14407: Regression of Cardiac AL Amyloid by Cardiovascular Magnetic Resonance. Circulation. 134. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact